0 followers
NeuExcell is an early stage gene therapy company focusing on neurodegenerative diseases. They have developed a disruptive neural repair technology that utilizes in vivo astrocyte-to-neuron conversion.
CEOs
Calico
6 followers
Qualigen Therapeutics
3 followers
Vera Therapeutics
2 followers
Cargo
1 follower
Capricor Therapeutics
1 follower
Edgewise Therapeutics
1 follower
Cartesian Therapeutics
1 follower
ADARx Pharmaceuticals
3 followers
Thermo Fisher Scientific
180 followers
Gilead Sciences
136 followers
Biogen
123 followers
Explore companies